Follow live coverage as Norwich City face Stoke City in the Championship today. An increasingly competitive second tier in ...

With the USMNT in need of healthy, in-form strikers, Josh Sargent is answering the call as the Norwich striker now has seven ...

A dad was diagnosed with four of the deadliest brain tumours after feeling 'tingles' in his left arm for a month - and died ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

Chardan Capital reissued their buy rating on shares of Stoke Therapeutics (NASDAQ:STOK – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a $24 ...

Norwich comfortably saw off Stoke 4-2 at Carrow Road to record their first win in four matches and reignite their bid to ...

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...

The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

Norwich City will look to keep their play-off hopes alive when they welcome Stoke City to Carrow Road on Saturday afternoon ...